This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Lamotrigine and serious skin reactions

Authoring team

A skin rash occurs in 5-10% of patients treated with lamotrigine (typically within the first 6 weeks of treatment). Serious skin reactions occur in about 1 in 1000 patients, including Stevens Johnson syndrome and toxic epidermal necrolysis. The risk of serious skin reactions is much higher in children with a frequency of 1:300 to 1:100 (1).

Risk factors for the development of skin reactions include (2):

  • concomitant use of sodium valproate
  • exceeding the starting dose of lamotrigine
  • exceeding rate of dose excalation of lamotrigine

Reference:

  • Drugs and Therapeutics Bulletin (1992), 30 , 75-76.
  • Current problems in pharmacovigilance (1997), 23, 8.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.